Exclusive: Route raises $40 million Series C at a $1.4 billion valuation [Fortune]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Fortune
A quick search in my email shows that I've unwittingly used Route to track packages for years, and for everything—Anthropologie candles, Nike sneakers, Alo sweatpants, and whatever it is I apparently needed from someplace called Heaven Mayhem. But behind those emails (and extensive online shopping) is a business that may not be a household name but which has attained—and retained—its unicorn valuation even as the VC sector has gone into a downturn. Route has raised $40 million in its Series C, valuing the company at $1.4 billion, Fortune can exclusively report. The round was led by Hanaco VC, and included Jaws Ventures, Madrona Ventures, and Granger. Investors in previous rounds include Upfront Ventures and Craft Ventures. Though unicorn-high valuations always garner attention, Route's is notable for its resilience: While the post-money $1.4 billion valuation is only a slight uptick from Route's $1.25 billion valuation in 2022 (when it raised a $200 million Series B) it's still
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%GlobeNewswire
- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Raymond James from $81.00 to $83.00. They now have an "outperform" rating on the stock.MarketBeat
- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.MarketBeat
- ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera SciencesGlobeNewswire
ANIP
Earnings
- 8/6/24 - Beat
ANIP
Sec Filings
- 9/20/24 - Form 8-K
- 9/16/24 - Form 4
- 9/16/24 - Form 8-K
- ANIP's page on the SEC website